<DOC>
	<DOCNO>NCT02835144</DOCNO>
	<brief_summary>The prevalence addictive disorder old age increase . Age specific appropriate therapeutic concept tailor in-patients thus represent promise approach future . The investigated therapeutic intervention `` therapy program integrate qualified acute treatment alcohol drug problem '' ( TIQAAM ) .</brief_summary>
	<brief_title>Substance Use Elderly Individuals : Brain Cognitive Correlates Effect Psychotherapy</brief_title>
	<detailed_description>The prevalence addictive disorder old age increase . Age specific appropriate therapeutic concept tailor inpatient thus represent promise approach future . The investigated therapeutic intervention `` therapy program integrate qualified acute treatment alcohol drug problem '' ( TIQAAM ) . Subjects ≥ 65 year , accord WHO ASSIST V3.0 risky consumption alcoholic beverage , benzodiazepine / non-benzodiazepine hypnotic ( zolpidem , zopiclone , zaleplon ) , , examine psychotherapeutic intervention inpatient stay exist . The data collect part 1 study pertain social integration , motivation change , quality life old age , general psychiatric symptom . The data collect part 2 study pertain brain structure function . Data standard procedure correlate data above.These relate psychiatric symptom , past consumption behavior , cognitive ability , perceive social support risk appetite .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>Subjects age 65 , accord WHOASSIST V3.0 , hazardous consumption alcoholic beverage / benzodiazepine / nonbenzodiazepine hypnotic ( zolpidem , zopiclone , zaleplon ) The subject must able understand verbal write information study flow content give write consent . The subject must able understand perform verbal write task ( cognitive test / questionnaire ) Taking medication could affect cognition outside benzodiazepine / nonbenzodiazepine hypnotic ( zolpidem , zopiclone , zaleplon ) . Drug treatment anxiolytic ( benzodiazepine ) part ongoing drugassisted detoxification Taking antidepressant medication Taking sleepinducing substance ( example Dipiperon® , Trittico® , Valverde Sleep® Valverde Entspannung® ) Taking anxiolytic active substance ( example , pregabalin , Opipramol ) . The use medication allow treat somatic disease . Use drug substance dependence . Except alcohol , benzodiazepine nonbenzodiazepine hypnotic ( zolpidem , zopiclone , zaleplon ) Diseases prevent subject give consent study impair cooperation investigation . Severe / unstable physical illness : severe depression , severe mania , delirium , severe cognitive impairment ( minimental status test &lt; 20/30 point ) , dementia Alzheimer type dementia , multiple sclerosis , clinically manifest structural brain damage ( eg cerebral hemorrhage , brain tumor , MRI find Schulthess clinic ) Heavily impaired vision eye diseases Additional exclusion criterion part 2 study : Pacemaker , implantable cardioverter defibrillator ( ICD ) , neurostimulator , aneurysm clip , prosthetic heart valve , valve prosthesis , metal prosthesis Clips surgery , metallic bone plate , artificial joint , metal fragment body , professional metal processing industry , nonremovable piercing , ferruginous tattoo ink Pregnancy Claustrophobia Use alcohol consciousnessaltering substance within 24 hour prior MRI scan ( exception : see `` exclusion criterion '' )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>